|
|
.
See Category: Certain infectious and parasitic diseases
ICD-10 (CM) Code and Descriptor
|
B78.9 |
Strongyloidiasis, unspecified
|
B789 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 32.71%
|
19.66%
|
10.68%
|
7.46%
|
6.78%
|
5.08%
|
3.73%
|
3.05%
|
2.37%
|
3.05%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for B78.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
79
|
79
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
61
|
61
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
43
|
43
|
|
87177
|
OVA AND PARASITES SMEARS |
33
|
34
|
|
86682
|
HELMINTH ANTIBODY |
32
|
32
|
|
87209
|
SMEAR COMPLEX STAIN |
32
|
33
|
|
80053
|
COMPREHEN METABOLIC PANEL |
27
|
27
|
|
J9145
|
INJECTION, DARATUMUMAB 10 MG |
24
|
990
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
15
|
15
|
|
G0467
|
FQHC VISIT, ESTAB PT |
14
|
14
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
13
|
13
|
|
96401
|
CHEMO ANTI-NEOPL SQ/IM |
13
|
13
|
|
83883
|
ASSAY NEPHELOMETRY NOT SPEC |
13
|
14
|
|
82784
|
ASSAY IGA/IGD/IGG/IGM EACH |
12
|
18
|
|
83735
|
ASSAY OF MAGNESIUM |
11
|
11
|
|
96413
|
CHEMO IV INFUSION 1 HR |
10
|
10
|
|
G2025
|
DIS SITE TELE SVCS RHC/FQHC |
10
|
10
|
|
J8540
|
ORAL DEXAMETHASONE |
10
|
1,600
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
9
|
9
|
|
84100
|
ASSAY OF PHOSPHORUS |
9
|
9
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
B78.9 related to the following DRG Codes:
391-392
974-976
|
